Strides Pharma Science Limited — Investor Meet, 22-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Strides Pharma discussed the financial results for the quarter and financial year ended March 31, 2025, focusing on revenue, profitability, and margin trends. Management highlighted key growth drivers, operational efficiencies, and strategic priorities to strengthen market presence. The call included updates on order inflows and execution momentum. Analysts inquired about product pipeline and geographical expansion, with management providing clarity. The overall tone conveyed confidence in sustaining growth and improving margins amid competitive challenges.